Going over the announcements from 2014 one has to question how...

Going over the announcements from 2014 one has to question how well the CNL board have keep the market informed.   The following are some of the stand out questions:

Table 3  in the 2014 Annual Report to shareholders lists 17 holes with phosphate intercepts, but no assays for Kef el Luz North.

Why have the assays for these holes never been announced?
What impact did the results have on the resource?
If these results were available to the market what impact would they have had on the share price?
Would the two major shareholders, Lion Selection and Polo Resources have been able to get control of Celamin by way of a highly dilutionary discounted rights issue?
If the results aren't included the current Mineral Resource of 130 Mt at 20.5% P2O5, how could the company commence a DFS study (see below)?

What was the offer from Psons (Seen announcements relating Take Overs Panel hearings 10 November 2014 )?

Why was this alternative to the rights issue never put to Celamin's shareholders at the AGM?

On 6 August it was announced and claimed again in the Presentation at the AGM in 21 November 2014  that a 2 stage DFS had commenced.

Where is study at?
What impact has the current legal action in Tunisia had on this study?  Has it stopped?
How much money has the company spent on the work to date?



Fergus
One seriously pissed off shareholder.